Pfizer Cdr [Cad Hedged] (PFE.NE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Cboe CA]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Cboe CA]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PFE.NE | ||||
| Company | Pfizer Cdr [Cad Hedged] | ||||
| Price Information | |||||
| Exchange | Cboe CA | ||||
| Open | 11.3600 | ||||
| High | 11.4200 | ||||
| Low | 11.3100 | ||||
| Latest | 11.3400 | ||||
| Change | -0.0300 | ||||
| % Change | -0.26% | ||||
| Volume | 132,947 | ||||
| 20-Day Average Volume | 159,666 | ||||
| Previous Close | 11.3700 | ||||
| Industry | N/A | ||||
| Has Options | No | ||||
| Technicals | |||||
| 20-Day Moving Average | 11.5878 | ||||
| 20-Day Raw Stochastic | 21.98% | ||||
| 20-Day Relative Strength | 47.11 | ||||
| Weighted Alpha | -5.43 | ||||
| Today's Opinion | 56% Buy | ||||
| Previous Opinion | 72% Buy | ||||
| Last Month's Opinion | 40% Buy | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.91% since 12/11/25 | ||||
| Low | 11.2900 on 12/16/25 | ||||
| High | 12.0500 on 12/15/25 | ||||
| 1-Month | |||||
| %Chg | -1.90% since 11/18/25 | ||||
| Low | 11.0300 on 11/20/25 | ||||
| High | 12.0500 on 12/15/25 | ||||
| 3-Month | |||||
| %Chg | +2.90% since 09/18/25 | ||||
| Low | 10.7600 on 09/25/25 | ||||
| High | 12.6000 on 10/03/25 | ||||
| 6-Month | |||||
| %Chg | +3.47% since 06/18/25 | ||||
| Low | 10.5800 on 08/01/25 | ||||
| High | 12.6000 on 10/03/25 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | 195,864,692 | ||||
| Shares Outstanding, K | 16,743,125 | ||||
| Annual Sales | 63,627,000,000 | ||||
| Annual Net Income | 8,031,000,000 | ||||
| Last Quarter Sales | 16,654,000,000 | ||||
| Last Quarter Net Income | 3,541,000,000 | ||||
| 60-Month Beta | 0.34 | ||||
| Per-Share Information | |||||
| Most Recent Earnings | 0.21 on 11/04/25 | ||||
| Latest Earnings Date | N/A | ||||
| Most Recent Dividend | 0.194 on 01/23/26 | ||||
| Next Ex-Dividends Date | 01/23/26 | ||||
| Ratios | |||||
| Price/Earnings ttm | 14.08 | ||||